I Love Neuro 303: Hybrid Assistive Limb (HAL) + Neuroplasticity = Improved Outcomes For Individuals With Neurologic Conditions
In this episode, Erin Gallardo, PT, DPT, NCS interviews physical therapist Mariah King, PT, DPT from RISE Healthcare Group and Hiroki (Hiro) Kimura from Cyberdyne about the HAL (Hybrid Assistive Limb) robotic exoskeleton and its role in neurologic rehabilitation. They discuss how the HAL system reads patients' intent to move via surface EMG signals and converts those signals into assisted movement to drive neuroplasticity and functional recovery for people with spinal cord injury, stroke, TBI, Parkinson's disease, and progressive neuromuscular disorders such as MS, SMA, and muscular dystrophy. Mariah explains RISE's one-on-one outpatient model, how patients are evaluated for HAL use, typical dosing (2–3x/week over about 2 months), and the outcome measures they track, including 10-Meter Walk, 2-Minute Walk, 30-Second Sit-to-Stand, and TUG. She shares powerful case examples, including a person with MS who relies on a wheelchair for mobility progressing to prolonged standing and assisted gait, and another individual with MS whose falls dropped from several per month to just one across four months. Hiro digs into what makes HAL unique compared to other exoskeletons: its emphasis on intention-based control, the ability for therapists to visualize and shape EMG patterns (for example, reducing co-contraction), and asymmetric or joint-specific assistance tailored to each limb. They also touch on the different HAL configurations (lower limb, single-joint, lumbar), its current status as a clinic-based rehab device (not take-home), billing considerations, the new pediatric version and forthcoming wrist device, as well as opportunities for students, clinicians, and clinic owners to get involved with RISE's HAL programs.
Website: www.risehealthcaregroup.com
Instagram: risehealthcaregroup
Facebook: risehealthcaregroup
YouTube: https://www.youtube.com/@risehealthcaregroup7766
Cyberdyne USA Inc.